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p53and glucose metabolism are associated with the development of diabetes. Insulin
signalling is initiated by the binding of insulin to its receptor and triggering cascades of events including
activation of PI3kinase/Akt signalling pathway. Calreticulin (CRT) is a calcium binding chaperone molecule
located in the endoplasmic reticulum. Targeted deletion of CRT in mice is embryonic lethal as a result of
developmental and metabolic abnormalities. Rescued CRT null mice develop severe hypoglycemia the reason
for which is not known. In addition, ventricular cardiomyocytes isolated from CRT null (crt−/−) mice have
increased glycogen deposits. Therefore, the aim of this study was to investigate the changes in the glucose
uptake and insulin signalling pathway (mainly PI3 kinase/Akt) in the absence of CRT. Here we show a
signiﬁcant increase in the glucose uptake by the crt−/− cells. This increase was accompanied by a signiﬁcant
increase in both insulin receptor β expression, Insulin receptor substrate-1 phosphorylation, GLUT-1
expression and in insulin stimulated Akt phosphorylation and kinase activity in the crt−/− cells. Intriguingly,
the increased expression of insulin receptor β in the crt−/− was due to decreased levels of p53 protein. The
current study is the ﬁrst evidence for the up-regulation of insulin receptor density and activity in the absence
of CRT function.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The pathogenesis of type 2 diabetes results from the inability of
cells, particularly skeletal muscle cells, to uptake glucose in an insulin
dependent manner. Insulin mediated glucose uptake is facilitated via
activation of insulin receptor thus activating insulin receptor
substrate-1 (IRS-1)-dependent phosphatidylinositol 3-kinase (PI3
Kinase) [34]. Receptor mediated stimulation of PI-3 kinase induces
phosphatidylinositol phosphorylationwhich facilitate translocation of
Akt to the plasma membrane. Akt, also known as protein kinase B, is a
serine/threonine kinase involved in regulating cell survival, prolifera-
tion, apoptosis and insulin response [3]. Translocation of Akt to the cell
membrane results in its phosphorylation at threonine-308 (T308)
residue by PDK-1 [38] and the serine-473 (S473) residue. The identity
of the kinase responsible for S473 phosphorylation has long been
under debate [26,36,40]. However, recently the rictor-mTOR complex
was shown to directly phosphorylate Akt at S473 in vivo [29]. Akt in
turn phosphorylates many target proteins including GSK3β [6,8].Sciences, St. Boniface General
, Manitoba, Canada R2H 2A6.
l rights reserved.Calreticulin (CRT) is an endoplasmic reticulum resident protein
with several biological functions including being a chaperone of
nascent glycoproteins and a regulator of Ca2+ homeostasis [19]. Gene
targeted deletion of CRT results in embryonic lethality [18] which
could be partially rescued by crossing thesemicewith transgenic mice
overexpressing activated calcineurin B in the heart [9]. However, the
rescued mice are growth retarded and present with signiﬁcant
hypoglycemia which is of unknown origin [9]. A role for CRT has
also been demonstrated in the folding of insulin receptor [2] and the
stability of glucose transporter-1 (GLUT-1) mRNA [35]. Furthermore,
ultrastructural analysis of the ventricular cardiomyocytes of the CRT
knockout embryos has shown signiﬁcant increase in glycogen
deposition as compared to wild type controls [15]. This build-up of
glycogen suggests that in the absence of CRT the insulin signalling and
glucose metabolism are changed. One could then postulate that loss of
CRT function could alter insulin receptor density and activity leading
to hypoglycemia. In addition to change in glucose uptake, activation of
insulin receptor can lead to activation of the PI3 kinase/Akt pathway
leading to activation of Mdm-2 [8]. Akt phosphorylates Mdm-2 on two
serine residues (S166 and S186) resulting in its translocation to the
nucleus [1,16]. In the nucleus Mdm-2 can inhibit p53 function via
interfering with its transcriptional activities and inducing p53
ubiquitination thereby targeting it for proteasome degradation
[7,25]. Previously, we have shown increased nuclear localization of
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All primers were designed using the published mouse sequences.
Fig. 1. Changes in insulin receptor β expression level in cells with altered CRT
expression. (A) A representative western blot for insulin receptor β (IR β) subunit in
wild type (wt) and calreticulin deﬁcient (crt−/−) MEF cells. Bar graph shows a signiﬁcant
increase in the ratio of insulin receptor β subunit to actin in the crt−/− cells as compared
to the wt cells. (B) RT-PCR showing the mRNA expression level of IR and GAPDH
(internal control) in wt and crt−/− cells. Bar graph represents a signiﬁcant increase in
the ratio of IR to GAPDH mRNA level in the crt−/− cells as compared to the wt cell. Data
presented are mean±SE of 4–5 different experiments. ⁎pb0.05, signiﬁcantly different
from the wt cells.
2345S. Jalali et al. / Biochimica et Biophysica Acta 1783 (2008) 2344–2351Mdm-2 and decreased level of p53 protein in crt−/− cells [17].
However, no data is available on the changes in activity of insulin
receptor or its downstream PI3 kinase/Akt signalling pathways upon
altered CRT expression (or function). Therefore, the aim of this study
was to investigate the changes in insulin signalling and its down-
stream PI3 kinase/Akt pathway in the absence of CRT.
2. Materials and methods
2.1. Materials
PI3 kinase inhibitors, wortmannin, Ly294002 and MG132 were
purchased from Calbiochem (EMD Biosciences Inc., USA). Antibodies
used were actin (Sigma-Aldrich, St. Louise, USA), GSK3β and insulin
receptor (β-subunit) (Chemicon International Inc., USA). Akt kinase
assay and all other antibodies were from Cell Signalling Technology
(Pickering, ON, Canada). Serine/threonine and tyrosine phosphatase
assay kits were fromMolecular Probes (Invitrogen, Canada). Enhanced
green ﬂuorescent protein-p53 (EGFP-p53) was purchased from
Clontech Laboratories (California, USA).
2.2. Cell culture
Wild type (wt) and calreticulin deﬁcient (crt−/−) mouse embryonic
ﬁbroblast (MEF) cells were isolated from 14-day oldmouse embryos as
described previously [17]. 106 cells were plated in Dulbecco's modiﬁed
Eagle's medium (DMEM) containing 10% FBS. 24 h after plating, the
cells were starved by ﬁrst washing with PBS then incubation in DMEM
containing 0.5% bovine serum albumin for 14–16 h. Cells were then
stimulated for 10 minwith DMEM alone or DMEM containing 100 nM
Insulin. To determine the role of PI3 kinase in the observed responses,
cells were incubated with 200 nM wortmannin or 10 μM LY294002 in
DMEM1 h prior to stimulationwith insulin. Cells were lysedwith RIPA
buffer (containing 250mMNaCl, 20 mM Tris, 1 mM EDTA,1 mM EGTA,
1 mM sodium vanadate, 30 mM sodium ﬂuoride, 10 mM tetrasodium
pyrophosphate, 0.5% sodium deoxycholate, 1% non-iodet p-40, 1%
Triton X-100; 0.5 μM PMSF and a protease inhibitor cocktail) followed
by centrifugation at 7000 rpm for 10min. The supernatants were used
for protein assay and western blot analysis.
2.3. Transient transfection
wt and crt−/− cells were transiently transfected with 10 μg of a
plasmid encoding CRT-HA (described in [17]) or EGFP-p53 using
Lipofectamine 2000. 48 h later, cells were lysed in RIPA buffer
containing protease inhibitors. 30 μg protein of total cell lysate were
used for western blot.
2.4. Western blot
Cell lysates containing 30 μg protein were separated on a 10% SDS-
polyacrylamide gel and blotted to nitrocellulose membrane. The
membrane was blocked with 5% milk powder in Tris-buffered saline(TBS) containing 0.1% Tween-20. The primary antibodieswere diluted in
appropriate dilution buffer as recommended by the manufacturer.
Cytoskeletal actin was used as a loading control for each blot. HRP-
conjugated secondary antibodies (Jackson Laboratories) were used
followed by enhanced chemiluminescence solutions. The bands corre-
sponding to each speciﬁc protein and actin were captured by Fluor-S
Max (Bio-Rad) andquantiﬁed usingBio-RadQuantityOne software. Data
were presented as the ratio of the speciﬁc proteins to the level of actin.
2.5. Akt kinase assay
Akt kinase activity was measured using an in vitro Akt kinase assay
(Cell Signalling Technology, Inc.) following the manufacturer's
instruction. Brieﬂy, cells were lysed using 1 ml lysis buffer supple-
mented with 1 mM PMSF. Cell lysates containing 500 μg protein and
20 μl immobilized Akt antibody were incubated 3 h at 4 °C, and then
centrifuged at 7000 rpm for 1 min. After washing with lysis buffer and
kinase buffer, the pellets were suspended in 40 μl kinase buffer
containing 200 μMATP and 1 μg GSK3 fusion protein. Themixture was
incubated at 30 °C for 30 min and the reaction was terminated by
adding 3× SDS sample buffer. Samples were resolved on SDS-PAGE gel
Fig. 2. Insulin receptor is activated in the absence of CRT. (A) Glucose uptake in wt and
crt−/− cells was measured in the presence and absence of insulin (0.1 or 1 μM). Cells
were starved in DMEM overnight and then incubated with a buffer containing 3H
deoxy-D-glucose with or without insulin (0.1 or 1 μM) for 10 min. Data presented are
mean±SE of pmole 3H-glucose uptake/mg protein, from three separate experiments
carried out in duplicates. ⁎pb0.05, signiﬁcantly different from the DMEM. †pb0.05,
signiﬁcantly different from the corresponding treated wt cells. (B) Glycogen content is
signiﬁcantly increased in CRT deﬁcient cells as compared to wt cells. Glycogen content
was determined using a modiﬁed phenol-sulfuric acid colorimetric technique as
described in “Materials and methods”. Total glycogen in cell lysate was then calculated
using a glycogen standard curve. The values were then normalized to the protein
content in each sample and presented as μg glycogen/μg protein. ⁎pb0.05, signiﬁcantly
different from wt cells.
Fig. 3. Expression of GLUT1 and GLUT-4 in CRT deﬁcient cells. (A) A representative RT-
PCR (upper panel) and western blot (lower panel) of four independent experiments
showing no change in GLUT-4 mRNA and protein in the absence of CRT. (B) A
representative RT-PCR showing GLUT-1 mRNA expression in crt−/− cells as compared to
wt cells. Bar graph shows mean±SE of ratio of GLUT-1 to GAPDH, from four different
experiments. (C) A representative western blot showing changes in GLUT-1 protein
expression in crt−/− cells as compared to wt cells. Bar graph shows mean±SE of ratio of
GLUT-1 to GAPDH, from three different experiments. ⁎pb0.05, signiﬁcantly different
from the wt.
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β antibody (1:1000 dilution).
2.6. Glucose uptake assay
To measure glucose uptake, wt and crt−/− cells were starved
overnight in DMEM. Next day, the cells were washed twice with 1 ml
Krebs-Ringer HEPES (KRH) buffer (121 mM NaCl, 4.9 mM KCl, 1.2 mM
MgSO4, 0.33 mM CaCl2, and 12 mMHEPES, pH 7.4) and incubated with
a cocktail of KRH buffer containing 0.1 mM deoxy-D-glucose and
1.0 μCi/ml deoxy-D-glucose, 2-[1,2-3H (N)] in either the presence or
absence of 100 nM insulin at 37 °C for 30min. Subsequently, cells were
washed with 1 ml cold KRH buffer containing 25 mM D-glucose and
lysed in 300 μl digitonin release buffer (0.25Mmannitol,17mMMOPS,
2.5 mM EDTA and 0.25 M digitonin). Cell lysates were centrifuged at
7000 rpm for 5 min and 100 μl of the supernatant was utilized to
determine the radioactivity in each sample using scintillation counter.
The amount of 3H-glucose in each sample was divided by protein
concentration and data is presented as pmole/mg protein.
2.7. Glycogen assay
To measure changes in cellular glycogen level upon loss of CRT
function a modiﬁed phenol-sulfuric acid colorimetric method wasused as described by Lo et al. [14]. Brieﬂy, wt and crt−/− cells were
grown to 80% conﬂuency. Cells were lysed using RIPA buffer and
digested using an alkaline digestion buffer (30% KOH saturated with
Na2SO4) followed by 10 min boiling. Total glycogen was then
precipitated using 95% ethanol. Glycogen was then re-dissolved in
distilled water. 5% phenol was then added to each tube followed by
addition of 96% sulforic acid and incubation on ice for 30 min. The
absorbance of each sample was then read using a microplate reader at
500 λ. The concentration of glycogen was then calculated using a
glycogen standard curve (concentration range 12–50 μg/ml). Protein
Fig. 4. Insulin mediated phosphorylation of Insulin Receptor Substrate-1 (IRS-1) is
elevated in the crt−/− cells. (A) Upper panel shows a representative western blot for p-
Insulin Receptor Substrate-1 (p-IRS-1) in wt and crt−/− cells. Cells were serum starved
overnight followed by incubation with DMEM containing 100 nM insulin for 10 min.
Cell lysates were then used for western blot with an antibody speciﬁc for p-IRS-1 (Tyr
941). Bar graph of mean±SE of ratio of p-IRS-1 band intensity to actin, from three
different experiments. (B) A representative western blot showing increased IRS-1
expression in crt−/− cells as compared towt cells. Bar graph is mean±SE of ratio of IRS-1
to actin intensity, from four independent experiments. ⁎pb0.05, signiﬁcantly different
from the wt.
Fig. 5. Akt kinase activity in the crt−/− cells. Upper panel shows a representativewestern
blot for p-GSK3α/β demonstrating Akt kinase activity in the wild type (wt) and crt−/−
cells. Cells were serum starved for 14–16 h followed by incubation with DMEM alone or
DMEMwith 100 nM Insulin for 10 min. Cell lysate was then used for immunoprecipitat-
ing Akt and subsequent Akt kinase assay as described in the “Materials and methods”.
Bar graphs show the mean±SE of four independent experiments. The intensity of p-
GSK3β band from the crt−/− cells is presented as percentage of the wt. ⁎pb0.05,
signiﬁcantly different from the wt.
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concentration was normalized to μg protein in each sample. Each
experiment was carried out in duplicates and the assay was repeated
with 7 different cell preparations.
2.8. Reverse transcriptase assay
To determine the level of insulin receptor transcription, total RNA
was isolated from the wt and crt−/− cells using RNeasy Mini Kit
(Qiagen). Isolated RNAs were subject to First-Strand cDNA synthesis
using SuperScript® II Reverse Transcriptase (Invitrogen), followed by
PCR ampliﬁcation for different genes (insulin receptor, GLUT-1, GLUT-
4 and GAPDH) using primers listed in Table 1. In preliminary
experiments the optimum Tm and cycle number for each gene PCR
ampliﬁcationwere determined. PCR for GAPDH, a housekeeping gene,
was carried out using the same cDNA as an internal control for
different samples. An aliquot of the PCR reaction was resolved on a 2%
agarose gel and visualized using the Bio-Rad Gel-Doc system. The
density of the bands corresponding to insulin receptor and GAPDH
were quantiﬁed using a Bio-Rad Quantity One Program (Cambridge,
MA). Data presented as the ratio of insulin receptor to GAPDH level
(mean±SE of three separate mRNA preparations).3. Results
3.1. Insulin receptor expression and function in crt−/− cells
A recent study showed that CRT deﬁcient mice that were rescued
from embryonic lethality by overexpression of activated calcineurin in
the heart, suffer from severe hypoglycemia [9]. Furthermore, glycogen
depositionwas signiﬁcantly higher in CRT deﬁcient mice as compared
to controls [15]. To determine the cause of this signiﬁcant decrease in
serum glucose level and glycogen deposition, we examined the
expression of insulin receptor in MEF cells isolated from the crt−/− and
wtmice. Fig.1A, demonstrates that there is a signiﬁcant increase in the
insulin receptor β subunit protein level in the crt−/− cells as compared
to the wt cells. Furthermore, this increase in insulin receptor β
expression is due to a signiﬁcant increase in its mRNA level (Fig.1B). To
investigatewhether the increase in insulin receptor β expression upon
deletion of CRT alters insulin receptor activity, we measured 3H-
glucose uptake in the wt and crt−/− cells. As shown in Fig. 2A, insulin
induced a signiﬁcant increase in glucose uptake in both wt and crt−/−
cells. However, the level of glucose uptake was signiﬁcantly higher in
the crt−/− cells following insulin stimulation as compared to the
insulin treatedwt cells (Fig. 2A). Fig. 2B shows that the higher glucose
uptake in crt−/− cells was accompanied by a signiﬁcant increase in
glycogen deposition in these cells when compared to similarly
culturedwt cells. Intriguingly, the non-treated crt−/− cells also showed
a slightly (but not signiﬁcantly) higher basal level of glucose uptake as
compared to the non-treated wt cells (Fig. 2A, DMEM). Therefore, we
examined the expression of glucose transporters GLUT-1, GLUT-3 and
GLUT-4 in wt and crt−/− cells. As shown in Fig. 3A, there was no
difference in the protein and mRNA level of GLUT-4 in wt and crt−/−
cells. However, GLUT-1 mRNA (Fig. 3B) and protein (Fig. 3C)
expression was signiﬁcantly higher in crt−/− cells as compared to wt
cells. Moreover, several attempts to detect GLUT-3 mRNA by RT-PCR
failed to show any message in both wt and crt−/− MEF cells (data not
shown). Similarly, using western blot analysis we did not detect any
GLUT-3 protein in these cells.
Fig. 6. Effect of Insulin on Akt phosphorylation in the wt and crt−/− cells. (A) Upper
panel shows a western blot with antibodies speciﬁc for p-Akt (S473), non-
phosphorylated Akt, and actin (loading control). Cells were serum starved for 14–16 h
followed by incubation with DMEM alone, or DMEM containing 100 nM Insulin for
10 min. Bar graph shows mean±SE of ratio of p-Akt band intensity to actin band
intensity, from four different experiments. ⁎pb0.05, signiﬁcantly different from the wt.
(B) A representative western blot carried out with antibody speciﬁc for the T308 p-Akt,
and non-phosphorylated Akt. Cells were serum starved then treated with DMEM or
Insulin. (C)Western blot shows that insulin induced phosphorylation of Akt at S473was
inhibited following pre-treatment of cells with wortmannin or LY294002. Cells were
serum starved and treated with 200 nM wortmannin or 10 μM LY294002 for 1 h then
treated with insulin in the presence of inhibitors for an additional 10 min.
Fig. 7. Insulin mediated phosphorylation of GSK3β in vivo. (A) The level of p-GSK3βwas
signiﬁcantly increased in crt−/− cells as compared to wt cells. Top panel is a
representative western blot with a p-GSK3β (S9) antibody. Lower panel is a bar graph
of mean±SE of ratio of p-GSK3β band intensity to actin band intensity, from three
different experiments. ⁎pb0.05, signiﬁcantly different from the insulin treated wt cells.
(B) Western blot analysis with GSK3β speciﬁc antibody showed no signiﬁcant change in
the endogenous level of GSK3β.
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downstream signalling molecule insulin receptor substrate 1 (IRS-1)
at tyrosine 941 (for review see [11]). Thus, we determined the level of
tyrosine 941 phosphorylation of IRS-1 as another measure of insulin
receptor function. As shown in Fig. 4A, there was a signiﬁcant (40%)
increase in IRS-1 phosphorylation in the absence of CRT. The increased
phosphorylation of IRS-1 was accompanied by a signiﬁcant increase inIRS-1 protein expression in crt−/− cells (Fig. 4B). These data suggests
that increased insulin receptor expression in crt−/− cells leads to
activation of its downstream signalling pathway, the PI3/Akt pathway.
3.2. Akt kinase activity and phosphorylation in crt−/− cells
Insulin can stimulate the PI3 kinase/Akt signalling pathway upon
binding to the insulin receptor. To test the effect of insulin on Akt
activation, wt and crt−/− cells were starved for 14–16 h and then
stimulated with DMEM alone, or DMEMwith 100 nM Insulin. As shown
in Fig. 5 (upper panel), Akt kinase activity was not detectable in cells
treatedwith DMEM alonewhereas insulin stimulated Akt kinase activity
in thewtandcrt−/− cells. The insulin inducedAkt activitywas signiﬁcantly
higher in the crt−/− cells as compared to the wt cells (Fig. 5).
Akt activation is mediated via its phosphorylation at a serine residue
(S473) in the kinase domain and at a threonine residue (T308) in the
regulatory domain [30]. Therefore, to test if the observed changes in the
Aktkinase activityweredue to increasedproteinphosphorylationordue
to increased Akt protein level itself, we performedwestern blot analysis.
Fig. 6A and B show that therewere no signiﬁcant differences in the level
of total Akt between the wt and crt−/− cells. Western blot analysis with
phospho-speciﬁc antibodies to Akt showed that insulin induced
phosphorylation of Akt at the two key residues S473 and T308 in both
cell types (Fig. 6A and B). However, insulin stimulated a more robust
phosphorylation of Akt in crt−/− cells as compared towt cells (Fig. 6A and
B). These results indicate that the increased Akt kinase activity observed
in the crt−/− cells was due to increased phosphorylation of Akt rather
than an increased level of Akt protein.
Akt activation can occur via PI3 kinase dependent or PI3 kinase
independent mechanisms. Thus, we examined the effect of PI3 kinase
inhibition on the insulin mediated increase in Akt phosphorylation
observed in the crt−/− cells. As shown in Fig. 6C, both wortmannin and
LY294002 treatment were able to completely abolish Akt phosphoryla-
tion at S473 following insulin stimulation in both crt−/− andwt cells.
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cells
Phosphorylation of GSK3β by Akt inhibits its function [12]. To
determinewhether theelevatedAkt activity can affect the level of GSK3β
phosphorylation in vivo, cell lysates from insulin treated andnon-treated
cells were used for immunoblotting. Insulin stimulation increased
GSK3β phosphorylation in both the wt and crt−/− cells (Fig. 7A).Furthermore, this increase in phosphorylated GSK3β was signiﬁcantly
higher in the crt−/− cells as compared to thewt cells (Fig. 7A). The change
in the in vivo phosphorylation level of GSK3β corresponds to the
increased Akt kinase activity (Fig. 5). Altered CRT expression has been
shown to affect the expression of different proteins such as calnexin, BiP
[13], p53 [17] and bradykinin receptor [22]. Thus, to determine whether
the observed increase in the in vivo phosphorylated GSK3β is due to
changes in its expression or phosphorylationwe carried outwestern blot
analysis with a non phospho-speciﬁc antibody to GSK3β. As shown in
Fig. 7B, therewasno signiﬁcant change in the level of totalGSK3βprotein
between the crt−/− andwt cells.
3.4. Altered CRT and p53 expression results in changes in insulin receptor
β protein levels
To determine the mechanism of increased insulin receptor β
expression (at mRNA and protein levels) in the crt−/− cells we
examined the ability of exogenously expressed CRT to reverse this
effect. wt and crt−/− cells were transiently transfected with CRT-HA
expression plasmid. Western blot for HA conﬁrms the expression of
exogenous CRT in the transfected cells (Fig. 8A, HA), albeit the level of
HA in the CRT-HA-crt−/− cells was higher as compared to the CRT-HA-
wt cells. However, the level of expression of CRT in the CRT-HA
transfected crt−/− cells was still signiﬁcantly less than the non-
transfected wt cells (Fig. 8A, CRT). Fig. 8A (IR β antibody) also
demonstrates that increasing CRT level decreases insulin receptor β
expression in both the wt and crt−/− cells. We previously showed that
loss of CRT function results in a signiﬁcant decrease in p53 protein
level and its function [17] which can be prevented upon inhibition of
proteasome activity (Uvarov and Mesaeli unpublished observations).
Furthermore, p53 has been shown to inhibit insulin receptor
expression by suppressing its promoter activity [39]. Thus we
examined whether decreased levels of p53 in the crt−/− cells could
result in increased insulin receptor expression. To investigate the
effect of increased p53 protein level, CRT deﬁcient cells were
transiently transfected with EGFP-p53 or treated with proteasome
inhibitors and insulin receptor β expressionwasmeasured by western
blot analysis. As shown in the Fig. 8B, transient transfection of crt−/−
cells with EGFP-p53 resulted in a signiﬁcant decrease in the insulin
receptor β protein level. Furthermore, Fig. 8C shows that treating the
crt−/− cells with MG132 (25 μg/ml for 8 h) results in a signiﬁcant
increase in the endogenous level of p53 proteinwhich is accompanied
by a signiﬁcant decrease in the insulin receptor β protein expression.
4. Discussion
Normal glucose metabolism is facilitated by signalling pathways
initiated by insulin [34]. As a result, any alteration at the level of
insulin or defect in insulin signalling can potentially contribute to the
development of diabetes. The present study is the ﬁrst to demonstrate
that CRT function is important in the regulation of glucose uptake and
insulin signalling pathway. In the current study we utilized MEF cellsFig. 8. Expression of insulin receptor β (IR β) in the crt−/− cells is regulated by increased
CRT or p53 expression. (A) A representative western blot showing the expression of IR β
in the cells transiently transfected with CRT. wt and crt−/− cells were transfected with
pcDNA-CRT-HA or pcDNA empty vector (controls). Cell lysates were utilized for western
blot analysis with IR β, HA, CRT and actin antibody. Bar graph is mean±SE of ratio of IRβ
band intensity to actin band intensity (from 4 separate experiments). (B) A
representative western blot showing the effect of p53 transfection on the level of IR β
protein expression in the crt−/− cells. wt and crt−/− cells were transiently transfected
with either EGFP or EGFP-p53 containing plasmid constructs. Cell lysates were used for
western blot analysis with IRβ, actin and p53. Bar graph is mean ± SE of ratio of IRβ
band intensity to actin band intensity (from 4 separate experiments). (C) A
representative western blot (n=2) shows the effect of proteasome inhibition on IRβ
and p53 protein expression level. The wt and crt−/− cells were treated with 20 μg/ml
MG132 for 8 h at 37 °C. Cells lysate were then used for western blot analysis with
antibodies to IR β, p53 and actin.
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Although these cells are not the typical insulin sensitive cell type (e.g.
skeletal muscle or adipocytes) but here we show that they do express
insulin receptor β, IRS-1, GLUT-1 and GLUT-4 (Figs. 2–4). Our results
demonstrate that targeted deletion of CRT signiﬁcantly induces insulin
mediated glucose uptake (Fig. 2A). This observation could explain the
reported severe hypoglycemia observed in the rescued CRT null mice
[9] and increased glycogen deposition in the myocardium of CRT null
embryos [15]. Indeed, our results in Fig. 2B show a signiﬁcant increase
in glycogen content of crt−/− cells. Furthermore, we illustrated that this
increased responsiveness to insulin was due to increased insulin
receptor β expression (Fig. 1), increased IRS-1 expression (Fig. 4B) and
phosphorylation (Fig. 4A), and elevated Akt phosphorylation and
function (Fig. 5–6). These changes were not due to the altered
expression level of Akt in the crt−/− cells (Fig. 6A). We also
demonstrated that increasedAkt phosphorylation following treatment
with insulinwas PI3 kinase dependent as this increase was completely
blocked by two different PI3 kinase inhibitors; wortmannin or
LY294002 (Fig. 6C). The increased activity of Akt in the crt−/− cells
leads to a higher level of phosphorylation of its endogenous substrate
GSK3β upon stimulation with insulin as demonstrated in Fig. 7. This is
in accordance with the data showing the increased accumulation of
glycogen in crt−/− cells (Fig. 2B) and the ventricular cardiomyocytes of
the CRT knockout embryos [15]. In fact, insulin mediated phosphor-
ylation of GSK3β has been shown to activate glycogen synthase and
increased glycogen accumulation [33].
Insulin activates the PI3 kinase/Akt signalling pathways [5] by
binding to the insulin receptor and inducing phosphorylation of IRS-1
[4]. Our data demonstrate that loss of CRT function results in a signiﬁcant
increase in the expression of insulin receptor β (Fig. 1). Many oligomeric
membrane receptors including insulin receptor undergo subunit folding
and assembly in the lumen of endoplasmic reticulum before they are
transported through the golgi apparatus to the cell membrane [2,28].
The process ofmaturation and folding recruits a number of endoplasmic
reticulum chaperones speciﬁcally the lectin-like chaperones (calnexin
and CRT) [10,19]. Previously, Bass et al., demonstrated a requirement for
calnexin/CRT function as lectin-like chaperones and Grp78 (non-lectin
chaperone) in the proper folding of the insulin receptor [2]. More
recently Saitoh et al., showed that the monomeric form of the insulin
receptor precursor binds to calnexin alone and the function of HSP90 is
necessary for insulin receptor dimerization and function [27]. Calnexin
and CRT are known to work synchronously as lectin-like chaperones to
ensure the proper folding of N-glucosylated proteins in the lumen of
endoplasmic reticulum [10]. Thus loss of CRT function might affect
folding of these proteins. However, in crt−/− cells the endoplasmic
reticulum levels of both calnexin and Grp78 are signiﬁcantly increased
[13,37]. Furthermore, our data showed that in the crt−/− cells the
increase in insulin receptor β subunit expression (Fig. 1A) was
accompanied by a similar increase in the mRNA of insulin receptor β
(Fig. 1B), and these cells demonstrated higher insulin receptor function
(Figs. 2 and 4). All together, these data exclude the possibility of direct
involvement of CRT chaperone function in insulin receptor folding,
maturation and function.
Our data also demonstrated that the increase in the insulin
receptor βwas due to decreased level of CRT protein (Fig. 8A). Indeed,
transient transfection of the wt and crt−/− cells with a plasmid
containing CRT-HA resulted in a signiﬁcant decrease in the insulin
receptor protein level. However, the level of insulin receptor protein
was still slightly higher in crt−/− cells (Fig. 8A, IRβ and bar graph)
which could be due to the low level of ectopic CRTexpression achieved
in these cells. Here we also showed that the increase in insulin
receptor β protein in crt−/− cells is due to increased levels of insulin
receptormRNA (Fig.1B). A recent paper demonstrated a role for CRT in
the down regulation of GLUT1 mRNA and protein level upon exposure
to high glucose [35]. Whether CRT could destabilize the insulin
receptor mRNA is not known and awaits further studies. However, inthe current study we show that the role of CRT on regulation of insulin
receptor mRNA is indirect and could be mainly mediated via
transcriptional regulation. p53 has been shown to suppress insulin
receptor promoter via C/EBP and Sp1 transcription factors [39].
Intriguingly, our previous study showed a signiﬁcant decrease in p53
protein level and function in the crt−/− cells [17]. Therefore, we
postulated that the increase in insulin receptor mRNA in the crt−/−
cells could be mediated by reduced repression of the insulin receptor
promoter by p53. Indeed, introduction of p53 into crt−/− cells resulted
in a reduction in insulin receptor β protein expression (Fig. 8B), which
implies the p53-mediated regulation of insulin receptor β expression
by CRT. Furthermore, as Fig. 8C shows, the inhibition of proteasome
activity by MG132 leads to increased p53 protein level which in
concomitant with a signiﬁcant reduction of insulin receptor β protein
in the crt−/− cells, again emphasizing the role of p53 in the regulation
of insulin receptor β in crt−/− cells. Several reports have demonstrated
that in addition to insulin receptor β, p53 negatively regulates the
promoter activity of insulin receptor substrate-3 [32], GLUT-1, GLUT-4
[31] and insulin like growth factor [24]. Indeed in crt−/− cells both
GLUT-1 and IRS-1 expression are signiﬁcantly increased (Figs. 3B,C,
and 4), however, we observed no change in GLUT-4 expression (Fig.
3A). As a regulator of Ca2+ homeostasis CRT [19] could regulate signal
transduction leading to gene regulation. Gene targeted deletion of CRT
results in a signiﬁcant increase in the basal level of cytosolic Ca2+
whereas no changes in the free endoplasmic reticulum Ca2+ content
was observed in these cells [23]. To date, no data is available on the
regulation of insulin receptor β or IRS-1 expression by altered
intracellular Ca2+ concentration. However, two early reports illu-
strated that increasing intracellular Ca2+ concentration results in a
signiﬁcant increase in GLUT-1 mRNA expression [20,21].
In conclusion, our data demonstrates that loss of CRT function in the
crt−/− cells reduces p53 protein expression thus inducing the expression
of insulin receptor β. Elevated insulin receptor β augment the cell's
responsiveness to insulin which is accompanied by elevated phosphor-
ylation of both IRS-1 and Akt. Increased Akt activity and enhanced
glucose uptake in the crt−/− cells can likely represents a mechanism of
the observed hypoglycemia in the rescued CRT deﬁcient mice. Overall,
our study provides the ﬁrst evidence for an indirect relationship
between CRT expression and insulin receptor expression and function.
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